🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Normal Eyes

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008Phase 21 site📍 Beijing Peking University People's Hospital · Tests: BCMA-CD19 CAR-T therapy Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis NCT07203391Phase 12 sites📍 Sydney📍 Melbourne St Vincent's Hospital, Sydney · Tests: roginolisib High Resolution Imaging OCT Study NCT07338461NA1 site📍 Milan Heidelberg Engineering GmbH · Tests: Autofluorescence Imaging, Infrared reflectance imaging, OCT imaging, OCTA imaging Tebentafusp-tebn With LDT in Metastatic UM NCT06626516Phase 1, Phase 21 site📍 Philadelphia Thomas Jefferson University · Tests: Tebentafusp-Tebn, GM-CSF (Sargramostim), BCNU A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases NCT07284797Phase 11 site📍 Melbourne Xencor, Inc. · Tests: XmAb657 Investigation of Neurovascular Coupling in Glaucoma Patients and Healthy Subjects NCT03870230NA1 site📍 Vienna Medical University of Vienna · Tests: Fourier Domain Doppler Optical Coherence Tomography (FDOCT), Dynamic Vessel Analyzer (DVA), Pattern Electroretinography… Vasculitis Pregnancy Registry NCT02593565n/a1 site📍 Tampa University of Pennsylvania · Tests: Online questionnaires Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma NCT07136181Phase 1, Phase 23 sites📍 Scottsdale📍 Denver📍 Nashville Novelwise Pharmaceutical Corporation · Tests: NBM-BMX Capsule are proprietary products developed by Novelwise Pharmaceutical Corporation (Novelwise) for treatment of… A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease NCT07737743Phase 225 sites📍 Clearwater📍 Tampa📍 Chicago Novartis Pharmaceuticals · Tests: DDY391, Placebo Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology NCT04648462n/a3 sites📍 Maastricht📍 Groningen📍 Delft Maastricht Radiation Oncology · Tests: ProTRAIT Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration NCT04040205Phase 24 sites📍 Jacksonville📍 Iowa City📍 St Louis Medical College of Wisconsin · Tests: Abemaciclib Physical and Psychosocial Parameters in Takayasu Arteritis and Behçet's Disease: A Comparative Study With Healthy Controls NCT07276087n/a1 site📍 Denizli ÖZLEM NUR TOK YAMAN · Tests: No intervention (observational study) Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases NCT06842316n/a1 site📍 Orléans Centre Hospitalier Régional d'Orléans · Tests: 1 blood sample, 40 mL (collection during a blood test, part of the standard of care for this disease) The Pathogenesis and Natural History of Sjogren's Disease NCT01425892n/a1 site📍 Bethesda National Institute of Dental and Craniofacial Research (NID… Intraglandular Treatment With Adipose-derived Mesenchymal Stem Cells in Patients With Xerostomia Due to Sjögren's Disease NCT06805448Phase 1, Phase 21 site📍 Copenhagen Copenhagen University Hospital, Rigshospitalet · Tests: MSC, Saline Water (Control) Modified CV Regimen in Optic Pathway Glioma NCT05278715Phase 21 site📍 Beijing Beijing Sanbo Brain Hospital · Tests: Carboplatin, Vincristine, Recombinant human endostatin Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: biologic sample preservation procedure, cytology specimen collection procedure Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT NCT01962415Phase 21 site📍 Pittsburgh Paul Szabolcs · Tests: Hydroxyurea, Alemtuzumab, Fludarabine, Melphalan, Thiotepa A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB) NCT06563414n/a1 site📍 Pittsburgh Krystal Biotech, Inc. Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface NCT04198740n/a2 sites📍 Montreal📍 Montreal Centre hospitalier de l'Université de Montréal (CHUM) · Tests: Tear sample collection via Schirmer strip and subsequent analysis by mass spectrometry Association Between Periodontitis and Dry Eye Disease: A Cross-Sectional Study NCT07873697n/a1 site📍 Sulaymaniyah University of Sulaimani Early Rehabilitation Using Head Impulse Test for Acute Vestibular Deficit NCT06660082NA1 site📍 Bron Hospices Civils de Lyon · Tests: Experimental treatment: Head movements, Sham treatment: only eye movements Transcorneal Electrical Stimulation for the Treatment of Visual Field Defects in Patients With Open-Angle Glaucoma NCT06682962NA1 site📍 Mainz Okuvision GmbH · Tests: Transcorneal electrical stimulation (TES) with the OkuStim 2 System Baricitinib in the Treatment of Intestinal Behçet's Syndrome NCT06849908Phase 22 sites📍 Beijing📍 Beijing Peking Union Medical College Hospital · Tests: Baricitinib, Adalimumab Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma NCT07276386Phase 21 site📍 Tampa H. Lee Moffitt Cancer Center and Research Institute · Tests: Melphalan/HDS (Percutaneous Hepatic Perfusion), Tebentafusp Deployment o the Multidisciplinary Prospective Cohort Imminent NCT04334031NA1 site📍 Lille University Hospital, Lille · Tests: Biobanking with genetic analysis, SF-12 questionnaire A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa NCT07016750Phase 35 sites📍 Rancho Santa Margarita📍 Coral Gables📍 Worcester Krystal Biotech, Inc. · Tests: KB803, Placebo Clinical Efficacy of Telitacicept in Sjögren's Disease With Interstitial Lung Disease NCT07843381n/a1 site📍 Beijing Peking University People's Hospital · Tests: Telitacicept 160mg, Conventional treatment Retinoblastoma Phase II Expanded Access Clinical Trial NCT06679634Phase 22 sites📍 New York📍 Milwaukee Targeted Therapy Technologies, LLC · Tests: Chemoplaque also referred to as Episcleral Topotecan
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy